Nir Naor serves as the Chief Financial Officer (CFO) at Axogen, Inc., a leading company in the field of peripheral nerve repair. With a robust background in finance and strategic planning, Naor has been instrumental in steering Axogen's financial strategies and growth initiatives. Before joining Axogen, Naor held significant roles in various high-profile companies, showcasing his expertise in financial management and operational efficiency. His career trajectory includes a notable stint as the CFO at Check-Cap Ltd., a medical diagnostics company, where he played a pivotal role in guiding the company through its IPO and subsequent growth phases. At Axogen, Naor's responsibilities encompass overseeing the company's financial operations, including budgeting, forecasting, and investor relations. His strategic vision has been crucial in navigating the complex landscape of the medical technology sector, particularly in advancing Axogen's mission to improve surgical treatment outcomes for peripheral nerve injuries. Under his leadership, Axogen has seen significant financial stability and growth, enabling the company to expand its product offerings and reach more patients worldwide. Naor's achievements at Axogen are not only reflected in the company's financial performance but also in its strengthened market position and enhanced shareholder value. Nir Naor's professional achievements extend beyond his role at Axogen. He holds a Master of Business Administration from Tel Aviv University and a Bachelor of Arts in Economics and Accounting from the Hebrew University of Jerusalem. His academic background, combined with his extensive experience in the medical and technology sectors, positions him as a key figure in Axogen's ongoing success. Naor's commitment to excellence and innovation continues to drive Axogen forward, making him a respected leader in the industry.